Foresite Capital Management Iv, LLC Vaxcyte, Inc. Transaction History

Foresite Capital Management Iv, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$18.66 - $29.16 $8.69 Million - $13.6 Million	-465,821 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$26.5 - $55.4 $4.11 Million - $8.59 Million	-155,000 Reduced 24.97%	465,821 $23 Million
Q2 2020 Aug 13, 2020	BUY	$26.15 - $35.45 $16.2 Million - $22 Million	620,821 New	620,821 $19.6 Million

354

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.42B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.